MatthewFlinnPullenMD
Infectious Disease • Minneapolis, MNHIV/AIDS Medicine, International Health, Travel & Tropical, Mycobacterial Disease
Infectious Diseases and International Medicine Fellow
Dr. Pullen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St SE T
Minneapolis, MN 55455Phone+1 612-626-9943Fax+1 612-625-4410
Education & Training
University of MinnesotaFellowship, Infectious Disease, 2016 - 2019
University of Tennessee (Nashville)Residency, Internal Medicine, 2013 - 2016
University of Tennessee Health Science Center College of MedicineClass of 2013
Certifications & Licensure
MN State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- NIH Fogarty Global Health Fellowship NIH, 2017-2018
Publications & Presentations
PubMed
- 859 citationsA Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.David R. Boulware, Matthew F Pullen, Ananta S. Bangdiwala, Katelyn A Pastick, Sarah M Lofgren
The New England Journal of Medicine. 2020-06-03 - 68 citationsOutpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase...Carolyn T Bramante, John B Buse, David M Liebovitz, Jacinda M Nicklas, Michael A Puskarich
The Lancet. Infectious Diseases. 2023-10-01 - 246 citationsHydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.Caleb P Skipper, Katelyn A Pastick, Nicole S Engen, Ananta S Bangdiwala, Mahsa Abassi
Annals of Internal Medicine. 2020-10-20
Press Mentions
Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCTJune 5th, 2020- University of Minnesota Trial Shows Hydroxychloroquine Has No Benefit over Placebo in Preventing COVID-19June 3rd, 2020
Grant Support
- Fogarty Global Health FellowshipNIH2017–2018
Research History
- Infectious Disease Fellow - Research trackMy project focuses on using novel sequencing techniques in a low or middle income country (LMIC) setting in Uganda to study the epidemiology of Mycobacterium tuberculosis complex disease.2016 - 2019
- Internal Medicine ResidentI worked in Dr. James Dale's lab as a research assistant working on the group A streptococcus (GAS) vaccine, focusing mainly on sequencing of GAS strains and phylogenetic tree analysis.2014 - 2015
- Medical studentSimilar work as mentioned above under "Internal Medicine Resident"2012 - 2013
- Research AssistantWorked as a research assistant in Dr. Lu Lu's lab, focusing mostly on sequencing of genes related to optic disorders, as well as dissection of mouse brain tissue for genetic analysis via the NerveNet database.2008 - 2009
- Research AssistantWorked as a research assistant in Dr. Carl Johnson's laboratory at Vanderbilt University, responsible for maintaining tissue cultures, as well as minor SNP analysis work related to a larger circadian rhythm project in the lab.2007 - 2008
Professional Memberships
- Member-in-training
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
